Speaking Faculty
Aris Persidis, Ph.D.President, Biovista
Clare Thibodeaux, Ph.D.Director of Scientific Affairs, Cures Within Reach
Dr. Bruce BloomFounder, Cures Within Reach, Chief Collaboration Officer, Healx
Laura Kleiman, Ph.D.Founder & CEO, Reboot Rx
Matthew Fedowitz, JDShareholder, Buchanan Ingersoll & Rooney
John SemanChief Executive Officer, Revitale Pharma
Santiago Ramon-Garcia, Ph.D.ARAID Investigator, Research and Development Agency of Aragon (ARAID) Foundation
James Doyle, Ph.D.Co-Founder and CEO, Modelis
Andrew Reaume, Ph.D., MBAPresident & CEO, Co-Founder, Melior Discovery
Stephen CaseyFounder & CEO, The 505(b)(2) Platform
Michael DerbyManaging Partner, TardiMed Sciences
Heather Mortiboys, Ph.D.Senior Lecturer, Associate Professor, University of Sheffield
David H. Crean, Ph.D., MBAPresident & CEO, Coast Bioventures
Malina Bakowski, Ph.D.Principal Investigator, Calibr at Scripps Research
Richard Wyse, MDDirector of Research & Development, Cure Parkinson's Trust
Sven Jacobson, MBACEO, Woolsey Pharmaceuticals, Co-Founder & CEO, Martin Pharmaceuticals
OM Sharma, Ph.D.Vice President, Bioinformatics, Innoplexus
Marco Schito, Ph.D.Executive Director, CURE Drug Repurposing Collaboratory (CDRC), Critical Path Institute
Rachel RubinVice President for Programs, Roivant Social Ventures